|
Sign In to gain access to subscriptions and/or personal tools.
|
Do Losartan and Atenolol have Differential Effects on BNP and Central Haemodynamic Parameters?
Justine Davies
Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee UK, j.i.davies{at}dundee.ac.uk
Elaine Carr
Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee UK
Margaret Band
Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee UK
Andrew Morris
Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee UK
Allan Struthers
Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee UK
Introduction. It has been suggested that angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin II receptor blockers (ARBs) have a differential effect on brachial and aortic haemodynamics. This is why they seem to have beneficial effects that are beyond brachial blood pressure (BP) lowering. We aimed to investigate if this was the case with losartan when compared to atenolol. We also investigated the differential effect of losartan and atenolol on the prognostic marker, brain type natriuretic peptide (BNP).
Methods. We studied 17 patients who were similar to those in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Patients were randomised to receive four months of losartan and atenolol in a crossover fashion. Main outcome measures were BNP and Augmentation index (AIx), which gives an indication of central haemodynamics. Brachial pulse wave velocity (PWV) and time to reflected wave (Tr) were measured as an indication of vascular stiffness.
Results. BNP was significantly lower on losartan than atenolol (p=0.007). AIx was lower on losartan than atenolol (p=0.03), however, this result was not significant when heart rate was considered as a covariate (p=0.09). Heart rate was significantly lower on atenolol than losartan (p=0.03). There was no difference between treatments for both brachial PWV and Tr (p=0.2 and p=0.99, respectively).
Conclusion. The benefits seen when losartan was compared to atenolol in the LIFE trial may be due to a reduction in BNP. We failed to detect a differential effect in central compared to peripheral haemodynamics when losartan was compared to atenolol.
Key Words: Blood pressure • Augmentation • Losartan • Atenolol
References
- Dahlof B., Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355:253-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hirata K., Vlachopoulos C., Adji A., O'Rourke MF Benefits from angiotensin-converting enzyme inhibitor `beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery? J Hypertens 2005;23:551-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Waring WS, Goudsmit J., Marwick J., Webb DJ, Maxwell SR Acute caffeine intake influences central more than peripheral blood pressure in young adults. Am J Hypertens 2003;16: 919-24.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kelly RP, Gibbs HH, O'Rourke MF et al. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990;11:138-44.[Abstract/Free Full Text]
- Chen CH, Ting CT, Lin SJ et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995;25:1034-41.et al. Prognostic role[Abstract/Free Full Text]
- Bhalla MA, Chiang A., Epshteyn VA et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 2004;44:1047-52.[Abstract/Free Full Text]
- Bibbins-Domingo K., Ansari M., Schiller NB, Massie B., Whooley MA B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003;108:2987-92.[Abstract/Free Full Text]
- de Lemos JA, Morrow DA, Bentley JH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345: 1014-21.[Abstract/Free Full Text]
- Olsen MH, Wachtell K., Tuxen C. et al. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy. J Hypertens 2005;23:1083-90.[Web of Science][Medline]
[Order article via Infotrieve]
- Davies JI, Struthers AD Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens 2003;21:463-72.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wilkinson IB, McEniery CM, Cockcroft JR Pulse waveform analysis and arterial stiffness: realism can replace evangelism and scepticism. J Hypertens 2005;23:213;author reply 213-14.[Web of Science][Medline]
[Order article via Infotrieve]
- Lemogoum D., Flores G., Van den AW et al. Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens 2004;22:511-17.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Williams B. Pulse wave analysis and hypertension: evangelism versus scepticism. J Hypertens 2004;22:447-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 6, No. 3,
151-153 (2005)
DOI: 10.3317/jraas.2005.022
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
